- Report
- November 2021
- 70 Pages
Global
From €3140EUR$3,500USD£2,703GBP
- Drug Pipelines
- June 2021
- 847 Pages
Global
From €2243EUR$2,500USD£1,931GBP
- Report
- April 2021
- 30 Pages
Global
From €2692EUR$3,000USD£2,317GBP
- Drug Pipelines
- March 2021
Global
From €2243EUR$2,500USD£1,931GBP
- Drug Pipelines
- March 2021
Global
From €1795EUR$2,000USD£1,545GBP
- Drug Pipelines
- March 2021
Global
From €3140EUR$3,500USD£2,703GBP
- Drug Pipelines
- March 2021
Global
From €1795EUR$2,000USD£1,545GBP
- Drug Pipelines
- March 2021
Global
From €2243EUR$2,500USD£1,931GBP
- Report
- October 2023
- 255 Pages
Global
From €2243EUR$2,500USD£1,931GBP
- Report
- October 2023
- 80 Pages
India
From €1346EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
Germany
From €1346EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
France
From €1346EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
China
From €1346EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
United States
From €1346EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1346EUR$1,500USD£1,158GBP
From €1346EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1346EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1346EUR$1,500USD£1,158GBP
- Report
- October 2023
- 100 Pages
Africa
From €1795EUR$2,000USD£1,545GBP
- Report
- March 2024
- 95 Pages
Global
From €3589EUR$4,000USD£3,089GBP

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more